| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.3 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |